Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose aetiology is
still unknown. Most hypotheses point out the gut-brain axis as a key factor for IBS. The axis is …

Introduction Irritable bowel syndrome (IBS), globally affecting 11.2% of the population and
imposing a direct annual cost of 1.7bn- 10 bn in the US, is one of the today's major …

Despite marked differences in underlying pathophysiology, the current management of
visceral pain largely follows the guidelines derived from the somatic pain literature. The …

Background: Irritable bowel syndrome (IBS) has a major negative influence on quality of life,
causing cramps, stomach pain, bloating, constipation, etc. Antispasmodics have varying …

Синдром раздраженного кишечника (СРК) является наиболее распространенным
функциональным расстройством желудочно-кишечного тракта, которое приводит к …

Methods: 40 patients of IBS-D were recruited from medicine out-patient department (OPD) of
a tertiary care hospital and randomized to two parallel groups. One received mebeverine …

Функциональные заболевания желудочно-кишечного тракта наносят ощутимый ущерб
системе здравоохранения. Частое их сочетание у одного и того же больного с …

Functional diseases of the gastrointestinal tract cause significant damage to the health care
system. Their frequent combination in the same patient with the migration of clinical …

Introduction: Lower urinary tract symptoms (LUTS) are common in patients suffering from
irritable bowel syndrome (IBS). LUTS are categorized into storage, voiding and …

Мета дослідження: оцінити клінічну ефективність препарату мебеверина (Спарк) в
корекції абдомінального больового синдрому та порушень стулу при СПК. Матеріали і …